On the other hand, somatic mutations in IDH, an enzyme that inter-converts isocitrate to α-ketoglutarate, were recently identified as occurring early in gliomatogenesis, with 70%–90% of low grade glioma and secondary glioblastoma multiforme found to harbor such mutations [149,150,151,152]. The gene discussed is IDH1; the disease is central nervous system cancer.